Non-Coding RNA and Frizzled Receptors in Cancer

Alex J Smith1, Kayla M Sompel1, Alamelu Elango1

  • 1Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Aurora, CO, United States.

Insights

Non-coding RNAs (ncRNAs) regulate frizzled receptors, impacting Wnt/β-catenin signaling in cancer. Understanding these ncRNA-frizzled interactions offers potential for novel cancer therapies targeting these receptors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Frizzled receptors are key regulators of Wnt/β-catenin signaling, implicated in tumorigenesis.
  • Non-coding RNAs (ncRNAs), including miRNAs, lncRNAs, and circRNAs, are increasingly recognized for their roles in cancer.
  • Dysregulation of ncRNAs affects the expression of oncogenic and tumor-suppressive proteins.

Purpose of the Study:

  • To review the current understanding of ncRNA molecules that modulate frizzled receptor expression and downstream signaling in cancer.
  • To explore the therapeutic potential of targeting ncRNA-frizzled receptor interactions for cancer prevention and treatment.

Main Methods:

  • Literature review of studies investigating ncRNA regulation of frizzled receptors.
  • Analysis of ncRNA involvement in Wnt/β-catenin pathway modulation in cancer contexts.
  • Synthesis of findings on the direct and indirect effects of ncRNAs on frizzled protein expression.

Main Results:

  • ncRNAs, such as miRNAs, lncRNAs, and circRNAs, directly or indirectly influence frizzled receptor expression.
  • These ncRNA-mediated regulatory mechanisms impact Wnt/β-catenin signaling, a critical pathway in cancer progression.
  • Evidence suggests a significant role for ncRNA-frizzled receptor interactions in various cancers.

Conclusions:

  • ncRNA molecules represent promising targets for developing novel cancer therapies aimed at modulating frizzled receptor signaling.
  • Further pre-clinical research is essential to translate these findings into effective clinical applications for cancer treatment and prevention.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
2.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K